Effect of L-tryptophan supplementation on eosinophils and eotaxin in guinea pigs

Experimental Biology and Medicine

Volumn 226, Issue 3, 2001, Pages 177-184

  Stahl, James L ^a   Cook, Ellen B ^a   Pariza, Michael A ^b   Cook, Mark E ^a,b   Graziano, Frank M ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

Eosinophilia myalgia syndrome; Eosinophils; Eotaxin; Guinea pigs; L tryptophan

Indexed keywords

CELLULOSE; EOTAXIN; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LYSATE; CELL MIGRATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA MYALGIA SYNDROME; GUINEA PIG; IMMUNOMODULATION; LEUKOCYTE COUNT; LUNG ALVEOLUS CELL; NONHUMAN; SKIN BIOPSY;

EID: 0034994426     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020122600304     Document Type: Article

References (38)

1. Metabolism and biology of tryptophan. Some implications
2. Indoleamine 2,3-dioxygenase. Purification and some properties
3. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon
4. L-Tryptophan and eosinophil-myalgia syndrome in New Mexico
5. Association of the eosinophil-myalgia syndrome with the ingestion of tryptophan
6. The EMS: What we know, what we think we know, and what we need to know
7. Comparative histopathologic evaluation of animal studies: Murine studies with L-tryptophan and constituents
8. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use
9. Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer
10. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan
11. Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome
12. Epidemiologic studies of the association of L-tryptophan with the eosinophil-myalgia syndrome: A critique
13. Bias or biology: Evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome
14. Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome
15. Scleroderma, fasciitis, and eosinophila associated with the ingestion of tryptophan
16. Tryptophan metabolism in man (with special reference to rheumatoid arthritis and scleroderma)
17. Pathophysiology of the eosinophilia-myalgia syndrome
18. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome
19. Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea pigs: The effect of anti-asthma drugs
20. Development of a prolonged eosinophil-rich inflammatory leukocyte infiltration in the guinea pig asthmatic response to ovalbumin inhalation
21. Epithelial cells are a major cellular source of the chemokine eotaxin in the guinea pig lung
22. Dietary phytoestrogens have anti-inflammatory activity in a guinea pig model of asthma
23. Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm
24. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung
25. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues
26. Eotaxin is required for the baseline level of tissue eosinophils
27. L-Tryptophan and the eosinophilia-myalgia syndrome: Current understanding of the etiology and pathogenesis
28. Production of guinea pig IgG1 homocytotropic antibodies to hapten-conjugated homologous serum albumin with different adjuvant combinations
29. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: Analysis in a guinea pig model in vivo
30. Antibody detection and preparation: Enzyme-linked immunosorbant assays
31. Involvement of host Fc receptors in antibody-mediated cutaneous basophil hypersensitivity reactions
32. Criteria for the definition of the eosinophilia-myalgia syndrome
33. Eotaxin and eosinophil recruitment: Implications for human disease
34. Species differences in L-tryptophan-kynurenine pathway metabolism: Quantification of anthranilic acid and its related enzymes
35. Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids
36. Tryptophan and its metabolite, kynurenine, stimulate expression of nerve growth factor in cultured mouse astroglial cells
37. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression
38. Implications of interferon-induced tryptophan catabolism in cancer, autoimmune diseases and AIDS